descriptive
Analysis v1
Strong Support
About half of all patients and over 60% of those with higher initial liver fat saw their liver fat drop by at least 30% after taking saroglitazar for 24 weeks. This finding is from the abstract summary - full study details were not available
32
0
Evidence from Studies
Supporting (1)
32
Community contributions welcome
32
Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients
Cross-Sectional Study
Human
2023 Sep 1Contradicting (0)
0
Community contributions welcome
No contradicting evidence found